Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.54 USD | +1.11% | -5.76% | +66.79% |
05-08 | Design Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-07 | Piper Sandler Upgrades Design Therapeutics to Overweight From Neutral | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+66.79% | 254M | |
+27.74% | 49.18B | |
+0.73% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.59% | 26.09B | |
-22.52% | 18.71B | |
+7.93% | 13.26B | |
+32.27% | 12.32B | |
-0.18% | 11.99B |
- Stock Market
- Equities
- DSGN Stock
- News Design Therapeutics, Inc.
- RBC Cuts Price Target on Design Therapeutics to $4 From $7 Amid Limited Near-Term Clinical Updates, Keeps Sector Perform, Speculative Risk